CNR Institutional Research Information System

DE FALCO, SANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.474
NA - Nord America 1.211
EU - Europa 509
SA - Sud America 509
AF - Africa 57
OC - Oceania 8
Totale 4.768
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.143
SG - Singapore 1.110
CN - Cina 512
BR - Brasile 413
VN - Vietnam 256
HK - Hong Kong 248
FR - Francia 162
IT - Italia 132
KR - Corea 106
JP - Giappone 53
DE - Germania 49
NL - Olanda 48
IN - India 39
GB - Regno Unito 34
BD - Bangladesh 29
CA - Canada 28
ID - Indonesia 28
AR - Argentina 27
FI - Finlandia 19
MX - Messico 18
ZA - Sudafrica 16
EC - Ecuador 14
PY - Paraguay 14
IL - Israele 13
TR - Turchia 13
EG - Egitto 11
SA - Arabia Saudita 11
CO - Colombia 10
ES - Italia 10
VE - Venezuela 10
RU - Federazione Russa 9
UZ - Uzbekistan 9
IQ - Iraq 8
PK - Pakistan 8
AU - Australia 7
CL - Cile 7
LV - Lettonia 7
MA - Marocco 7
BO - Bolivia 5
SE - Svezia 5
UY - Uruguay 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
KE - Kenya 4
PE - Perù 4
PL - Polonia 4
RO - Romania 4
TN - Tunisia 4
AT - Austria 3
IE - Irlanda 3
JO - Giordania 3
LT - Lituania 3
OM - Oman 3
PH - Filippine 3
SN - Senegal 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
DZ - Algeria 2
HU - Ungheria 2
IR - Iran 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
SV - El Salvador 2
AM - Armenia 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MZ - Mozambico 1
NC - Nuova Caledonia 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
Totale 4.766
Salva come PNG Salva come JPEG
Città #
Singapore 665
Santa Clara 416
Hong Kong 239
Hefei 221
San Jose 146
Lauterbourg 130
Ho Chi Minh City 110
Seoul 106
Beijing 76
Ashburn 72
Hanoi 50
Los Angeles 50
Dallas 48
São Paulo 35
Tokyo 35
New York 31
Naples 28
Frankfurt am Main 24
Buffalo 21
Marigliano 18
Guangzhou 16
Aversa 15
Helsinki 15
Minamishinagawa 14
Rio de Janeiro 14
Milan 12
Belo Horizonte 11
Avellino 10
Bengaluru 9
Da Nang 9
Düsseldorf 9
Porto Alegre 9
Toronto 9
Boardman 8
Curitiba 8
Asunción 7
Brooklyn 7
Cairo 7
Chicago 7
Council Bluffs 7
Goiânia 7
Haiphong 7
Hải Dương 7
Istanbul 7
Johannesburg 7
Mexico City 7
Nuremberg 7
Riga 7
Rome 7
Tashkent 7
Amsterdam 6
Baghdad 6
Biên Hòa 6
Dhaka 6
Guarulhos 6
Manchester 6
Ninh Bình 6
Orem 6
Phoenix 6
Portsmouth 6
Santiago 6
Atlanta 5
Brasília 5
London 5
San Francisco 5
Shanghai 5
Shenzhen 5
Campinas 4
Can Tho 4
Chengdu 4
Houston 4
Jakarta 4
Kingston 4
Lappeenranta 4
Lima 4
Montevideo 4
Montreal 4
Nairobi 4
Quito 4
Ribeirão Preto 4
Stockholm 4
Sydney 4
Vĩnh Long 4
Amman 3
Betim 3
Boston 3
Buenos Aires 3
Caracas 3
Caxias do Sul 3
Charlotte 3
Contagem 3
Cotia 3
Dakar 3
Dammam 3
Falkenstein 3
Ha Long 3
Jeddah 3
La Paz 3
Limeira 3
Liverpool 3
Totale 3.005
Salva come PNG Salva come JPEG
Nome #
Epigenetic control of hypoxia inducible factor-1?-dependent expression of placental growth factor in hypoxic conditions 101
Long Non-coding RNA T-UCstem1 Controls Progenitor Proliferation and Neurogenesis in the Postnatal Mouse Olfactory Bulb through Interaction with miR-9 98
Aflibercept in the treatment of diabetic macular edema: a review and consensus paper. 91
Recombinant humanized Fab fragments targeting the CFC domain of human Cripto-1 79
Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization 78
Small Interfering RNA Induced TLR3 Activation Inhibits Blood and Lymphatic Vessel Growth 73
alpha-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells 69
Placental growth factor variant for inhibition of vegf-dependent angiogenesis 65
New strategies to inhibit pathological angiogenesis 63
Use of a recombinant protein as receptor of a hepatitis virus 62
Placental growth factor-1 and -2 induce hyperplasia and invasiveness of primary rheumatoid synoviocytes 62
Suppression of Choroidal Neovascularization in PlGF -/- Mice Is Due to Elevated VEGF-A and VEGFR-1 Activation. 59
VEGFR1 signaling in retinal angiogenesis and microinflammation 58
Cancer-derived exosomal Alu RNA promotes colorectal cancer progression 57
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 57
PlGF and VEGF-A/PlGF Heterodimer are Crucial for Recruitment and Activation of Immune Cells During Choroid Neovascularization 56
L-Proline Induces a Mesenchymal-like Invasive Program in Embryonic Stem Cells by Remodeling H3K9 and H3K36 Methylation 56
Human IgG1 antibodies suppress angiogenesis in a target-independent manner. 55
Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression. 55
Prolyl 3-hydroxylase 2 is a molecular player of angiogenesis 53
Generation and testing of engineered multimeric Fabs of trastuzumab 53
Combined HAT/EZH2 modulation leads to cancer-selective cell death 53
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 51
Branched peptides for the modulation of protein-protein interactions: More arms are better than one? 50
The Cellmaker: a fully automated robotic platform to identify stem cell regulators 50
Identification of placenta growth factor determinants for binding and activation of Flt-1 receptor 50
Synthetic Peptide Libraries. From random mixtures to in vivo testing. 50
The Cellmaker: a fully automated robotic platform to identify stem cell regulators 50
Full Functional Knockout of Placental Growth Factor by Knockin with an Inactive Variant Able to Heterodimerize with VEGF-A 48
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases. 47
Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications. 47
An Automated High Throughput Screening-Compatible Assay to Identify Regulators of Stem Cell Neural Differentiation. 47
Synergistic interactions of PlGF and VEGF contribute to blood-retinal barrier breakdown through canonical NFkB activation. 47
Intravenous immune globulin suppresses angiogenesis in mice and humans. 46
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells. 44
A Novel Robotic Platform for Cell Based Phenotypic Assays Reveals a Key Role of Metabolites in the Control of Embryonic Stem Cell Metastability 43
Hypoxia activates placental growth factor expression in lymphatic endothelial cells 42
Retinal angiogenesis suppression through small molecule activation of p53 42
Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models 41
EMBO Workshop - Cell Migration, Tissue Invasion and Disease 40
Identification of Cripto inhibitors to direct cell fate specification in ES cells 39
Epigenetic regulation of hypoxia-induced PlGF expression 39
Placental growth factor regulates the generation of T(H)17 cells to link angiogenesis with autoimmunity 39
Control of embryonic stem cell metastability by L-proline catabolism 39
Anti-neuropilin-1 peptide inhibits synoviocyte survival, angiogenesis, and experimental arthritis. 38
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 37
Inhibition of pathological angiogenesis atagonizing VEGF Receptor 1 36
A placental growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism. 36
A placenta growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism 36
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers 34
Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models. 34
The vascular endothelial growth factors and receptors family: up to now the only target for anti-angiogenesis therapy. 34
Ribonucleases and angiogenins from fish. 33
A SMALL SYNTHETIC CRIPTO BLOCKING PEPTIDE IMPROVES DOPAMINERGIC DIFFERENTIATION AND FUNCTIONAL INTEGRATION OF MOUSE EMBRYONIC STEM CELLS IN A RAT MODEL OF PARKINSON S DISEASE 33
Propionyl-L-Carnitine Enhances Wound Healing and Counteracts Microvascular Endothelial Cell Dysfunction. 32
A placental growth factor variant unable to recognize VEGFR-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization 32
HUMAN L7A RIBOSOMAL-PROTEIN - SEQUENCE, STRUCTURAL ORGANIZATION, AND EXPRESSION OF A FUNCTIONAL GENE 31
Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models 31
Control of embryonic stem cell metastability by L-proline catabolism. 31
Placental growth factor variant for inhibition of vegf-dependent angiogenesis 30
A review on the in vitro activity of phosphorothioate oligonucleotides against Human Immunodeficency Viruses in vitro. 30
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases. 30
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. 29
Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide 29
Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia 29
Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells 28
Determinants of human placental growth factor for binding and activation of Flt-1 receptor. 28
The Role Of Placental Growth Factor In Hypoxia Induced Angiogenesis In The Adult Mouse Lung 28
Epigenetic control of hypoxia-induced Placental Growth Factor expression 28
Propionyl-L-carnitine improves post-ischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production 27
Inhibition of choroidal and corneal pathological neovascularization by Plgf-de gene transfer 27
Cripto Blocking molecules and therapeutic uses thereof 27
A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization 27
A PROTEASES-STABLE TERAMERIC TRIPEPTIDE ABLE TO ANTAGONIZE VEGF RECEPTOR 1. 26
Involvement of HIF-1alfa in hypoxia-induced Placental Growth Factor expression 26
Identification of inhibitors of PlGF/ Flt-1 interaction by the screening of peptide compounds libraries 26
NEW INHIBITORS OF VEGF-DEPENDENT ANGIOGENESIS ASSOCIATED TO OCULAR NEOVASCULAR DISEASES. 26
LIPOPROTEIN-MEDIATED DELIVERY OF ANTISENSE OLIGONUCLEOTIDES 26
PHARMACOLOGICAL TARGETING OF CRIPTO SIGNALING DIRECTS EMBRYONIC STEM CELL FATE AND IMPAIRS THEIR TUMORIGENIC POTENTIAL IN VIVO 26
A small synthetic cripto blocking Peptide improves neuralinduction, dopaminergic differentiation, and functional integration of mouseembryonic stem cells in a rat model of Parkinson's disease 26
An expression system for the single-step production of recombinant human amidated calcitonin 25
Antiangiogenesis therapy: an update after the first decade. 25
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells 25
Identification of Cripto-Alk4 inhibitors through the screening of combinatorial peptide libraries 25
The C. elegans pvf-1 gene encodes a PDGF/VEGF-like factor able to bind mammalian VEGF receptors and to induce angiogenesis 25
A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease 25
Role of placental growth factor and its receptor Flt-1 in rheumatoid inflammation: A link between angiogenesis and inflammation 25
Placental Growth Factor Variants for inhibition of VEGF-dependent tumor growth. 25
Inhibition of Choroidal and Corneal Pathologic Neovascularization by Plgf1-de Gene Transfer. 25
Inhibition of pathological angiogenesis antagonizing VEGF receptor I. 25
The Chemical Synthesis of Mouse Cripto CFC variants 24
A Review on the in vitro activity of phosphorothioate oligonucleotides against human immunodeficiency viruses 24
HBV binding protein (HBV-BP) is a potent cysteine protease inhibitor. 24
A synthetic ligand for IgA affinity purification 24
Flt-1 expression influences apoptotic susceptibility of vascular smooth muscle cells through the NF-{kappa}B/IAP-1 pathway 24
A combinatorial approach to direct neuronal fate specification from embryonic stem cells 24
Non-Targeted siRNA Suppress Angiogenesis in the Cornea, Dermis and Hind Limb 23
Corneal avascularity is due to soluble VEGF receptor-1 23
Anomalous distribution of the unaffected CTG repeats allele of DM patients 23
The biflavonoid Amentoflavone inhibits neovascularization preventing the activity of pro-angiogenic vascular endothelial growth factors 23
Totale 4.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.145
article - articoli 11.992
book - libri 102
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.239
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202447 0 0 0 0 0 0 0 0 5 1 36 5
2024/20251.978 19 14 162 75 435 121 12 83 38 75 515 429
2025/20262.868 135 292 310 467 559 81 411 153 183 172 105 0
Totale 4.893